Toggle Offcanvas
...
 
Ezetimibe Tenders

Ezetimibe Tenders

View Ezetimibe tenders, RFPs and contracts. Bid on readily available Ezetimibe tenders with the best and most comprehensive tendering platform, since 2002.
Ezetimibe is a cholesterol lowering drug that works by reducing the absorption of cholesterol in the intestines. It is often combined with statins for better lipid control.

Bidding for Ezetimibe tenders is extremely lucrative for companies of all sizes. Tendering authorities and private companies release thousands of contracts worth millions for procurement of Ezetimibe.

Global Tenders stands out as the largest platform dedicated to pharmaceutical tenders and government contracts. Boasting over 20 years of experience in the tender business, GlobalTenders offers the most extensive and reliable Tenders/RFPs/Contracts Database available. The platform aggregates contracts from both public and private sources, connecting with a vast network of over half a million buyers. Employing advanced artificial intelligence, our meticulous process involves gathering information from over a hundred thousand sources. The data is then intelligently categorized into thousands of subcategories for easy filtering and presenting it in a user-friendly format for quick comprehension.

In addition to tender information, we offer in-depth Ezetimibe market analysis, bid consultancy services, and insights into top bidders and winners.

Sign up now to get instant access to unlimited Ezetimibe tenders, advanced search filters, market analysis, industry trends, tender training and 24/7 customer support.

9 Live Notices for Ezetimibe Tenders

Showing 1 to 9

Pharmacy - Medicines
country Uruguay
posting date05 Sep 2025
deadline09 Sep 2025
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb) V For The Active Ingredient Bempedoic Acid + Ezetimibe, (Obo) Atc C10Ba10 For The Period 01.03.2025 - 28.02.2027
country Germany
posting date16 Jan 2025
deadline05 Jan 2027
Conclusion Of A Non-Exclusive Discount Agreement Pursuant To Section 130A Paragraph 8 Of The Social Security Code (Sgb V) For The Active Ingredient Bempedoic Acid + Ezetimibe, (Obo) Atc C10Ba10 For The Period 01.03.2025 - 28.02.2027
country Germany
posting date16 Jan 2025
deadline05 Jan 2027
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Bempedoic Acid And Ezetimibe (C10Ba10) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date14 Jun 2024
deadline31 May 2026
Conclusion Of Non-Exclusive Discount Agreements Pursuant To Section 130A Paragraph 8/130C Paragraph 1 Sgb V For Medicinal Products Containing The Active Ingredients Bempedoic Acid And Ezetimibe (C10Ba10) Within The Framework Of A So-Called Open-House Model.
country Germany
posting date13 Jun 2024
deadline31 May 2026
Medicines With The Active Ingredient Combination Bempedoic Acid And Ezetimibe (Atc: C10Ba10)
country Germany
posting date13 Oct 2023
deadline30 Sep 2025
Ezetimibe 10Mg Tab.
country India
posting date01 Sep 2025
deadline11 Sep 2025
Ezetimibe 10Mg Tab.
country India
posting date29 Aug 2025
deadline10 Sep 2025
Ethinyl Estradiol 0.01 Mg,Everolimus 5 Mg Tab,Eye Oint Ciprofloxacin,Ezetimibe+ Atorvastatin Tab Quantity: 13640
country India
posting date27 Aug 2025
deadline12 Sep 2025

Share Share this page